| The Therapeutic Potential of Naringenin: A Review of Clinical Trials |
66 |
| Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications |
37 |
| Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders |
35 |
| Roles of Heat Shock Proteins in Apoptosis, Oxidative Stress, Human Inflammatory Diseases, and Cancer |
34 |
| Old Drugs as New Treatments for Neurodegenerative Diseases |
33 |
| Gut Microbiota and Iron: The Crucial Actors in Health and Disease |
31 |
| Role of Microbiota and Tryptophan Metabolites in the Remote Effect of Intestinal Inflammation on Brain and Depression |
31 |
| Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth |
30 |
| Lutathera (R): The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy |
29 |
| TRPM Family Channels in Cancer |
27 |
| The Role of NCOA4-Mediated Ferritinophagy in Health and Disease |
24 |
| Influence of Iron on Bone Homeostasis |
23 |
| TRPA1 Antagonists for Pain Relief |
22 |
| Changing Trends in Computational Drug Repositioning |
20 |
| New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases |
20 |
| Iron Regulation: Macrophages in Control |
20 |
| Strategies for the Development of Glycomimetic Drug Candidates |
19 |
| Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Review of Classical and New Compounds: Part-I |
18 |
| The Role of TRP Channels in the Metastatic Cascade |
16 |
| Cysteine Cathepsin Protease Inhibition: An update on its Diagnostic, Prognostic and Therapeutic Potential in Cancer |
16 |
| Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy |
15 |
| Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature |
15 |
| Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease |
15 |
| Brain Iron Homeostasis: A Focus on Microglial Iron |
15 |
| Multidirectional Efficacy of Biologically Active Nitro Compounds Included in Medicines |
15 |
| TRP Channels and Migraine: Recent Developments and New Therapeutic Opportunities |
15 |
| Research Progress on Rolling Circle Amplification (RCA)-Based Biomedical Sensing |
14 |
| Antiviral Agents in Development for Zika Virus Infections |
14 |
| Developments in Carbohydrate-Based Cancer Therapeutics |
14 |
| In Silico Study to Identify New Antituberculosis Molecules from Natural Sources by Hierarchical Virtual Screening and Molecular Dynamics Simulations |
14 |
| Lipid Nanoparticles and Their Hydrogel Composites for Drug Delivery: A Review |
14 |
| BACE-1 and gamma-Secretase as Therapeutic Targets for Alzheimer's Disease |
14 |
| Sucrosomial (R) Iron: A New Generation Iron for Improving Oral Supplementation |
13 |
| Hepcidin Therapeutics |
13 |
| Antibiotic Persistence as a Metabolic Adaptation: Stress, Metabolism, the Host, and New Directions |
13 |
| Neurodegeneration with Brain Iron Accumulation Disorders: Valuable Models Aimed at Understanding the Pathogenesis of Iron Deposition |
13 |
| 2018 FDA Tides Harvest |
13 |
| The Multi-Functional Calcium/Calmodulin Stimulated Protein Kinase (CaMK) Family: Emerging Targets for Anti-Cancer Therapeutic Intervention |
12 |
| Aptamers as Diagnostic Tools in Cancer |
12 |
| Low Molecular Weight Chitosan-Coated PLGA Nanoparticles for Pulmonary Delivery of Tobramycin for Cystic Fibrosis |
12 |
| TRP Channels as Drug Targets to Relieve Itch |
12 |
| Emerging and Dynamic Biomedical Uses of Ferritin |
12 |
| Fighting Hypoxia to Improve PDT |
11 |
| Stereoselective Anti-Cancer Activities of Ginsenoside Rg3 on Triple Negative Breast Cancer Cell Models |
11 |
| Matrix Metalloproteinase in Abdominal Aortic Aneurysm and Aortic Dissection |
11 |
| 2017 FDA Peptide Harvest |
10 |
| Role of TRPV1 and TRPA1 Ion Channels in Inflammatory Bowel Diseases: Potential Therapeutic Targets? |
10 |
| Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer's Disease Treatment |
10 |
| Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules |
10 |
| Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity |
10 |
